0001209191-21-011290.txt : 20210217
0001209191-21-011290.hdr.sgml : 20210217
20210217164044
ACCESSION NUMBER: 0001209191-21-011290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN MARK ANDREW
CENTRAL INDEX KEY: 0001256708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 21645443
MAIL ADDRESS:
STREET 1: DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-16
0
0001308547
Dolby Laboratories, Inc.
DLB
0001256708
SHERMAN MARK ANDREW
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
0
1
0
0
EVP, GEN. COUN. & SECRTY
Class A Common Stock
2021-02-16
4
M
0
13000
45.50
A
63010
D
Class A Common Stock
2021-02-16
4
S
0
13000
95.00
D
50010
D
Employee Stock Option (right to buy)
45.50
2021-02-16
4
M
0
13000
0.00
D
2026-12-15
Class A Common Stock
13000
36118
D
Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest
This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**
/s/ Daniel Rodriguez, Attorney-in-Fact for Andy Sherman
2021-02-17